Entheon Biomedical Corp Stock Cash Per Share
| ENTBF Stock | USD 0.12 0.03 33.33% |
Entheon Biomedical Corp fundamentals help investors to digest information that contributes to Entheon Biomedical's financial success or failures. It also enables traders to predict the movement of Entheon OTC Stock. The fundamental analysis module provides a way to measure Entheon Biomedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Entheon Biomedical otc stock.
Entheon |
Entheon Biomedical Corp OTC Stock Cash Per Share Analysis
Entheon Biomedical's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current Entheon Biomedical Cash Per Share | 0.01 X |
Most of Entheon Biomedical's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Entheon Biomedical Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Entheon Biomedical Corp has a Cash Per Share of 0.01 times. This is 99.77% lower than that of the Healthcare sector and 99.77% lower than that of the Biotechnology industry. The cash per share for all United States stocks is 99.8% higher than that of the company.
Entheon Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Entheon Biomedical's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Entheon Biomedical could also be used in its relative valuation, which is a method of valuing Entheon Biomedical by comparing valuation metrics of similar companies.Entheon Biomedical is currently under evaluation in cash per share category among its peers.
Entheon Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.46 | |||
| Operating Margin | (60.27) % | |||
| Current Valuation | 1.12 M | |||
| Shares Outstanding | 59.09 M | |||
| Shares Owned By Insiders | 8.63 % | |||
| Price To Book | 0.22 X | |||
| Price To Sales | 9.60 X | |||
| Revenue | 21.67 K | |||
| Gross Profit | 9.13 K | |||
| EBITDA | (8.62 M) | |||
| Net Income | (8.89 M) | |||
| Cash And Equivalents | 467.58 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 300 K | |||
| Debt To Equity | 0.05 % | |||
| Current Ratio | 0.97 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (5.62 M) | |||
| Earnings Per Share | (0.11) X | |||
| Beta | 1.89 | |||
| Market Capitalization | 1.3 M | |||
| Total Asset | 9.98 M | |||
| Z Score | 2.4 | |||
| Net Asset | 9.98 M |
About Entheon Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Entheon Biomedical Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Entheon Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Entheon Biomedical Corp based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Entheon OTC Stock
Entheon Biomedical financial ratios help investors to determine whether Entheon OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entheon with respect to the benefits of owning Entheon Biomedical security.